Top Markets
#1 ONFA ONFA +217.91%
#2 Resolv wstUSR Resolv wstUSR +198.08%
#3 Noon Noon +41.33%
#4 Doge Strategy Doge Strategy +38.28%
#5 DeAgentAI DeAgentAI +36.64%
#6 NKN NKN +34.87%
#7 StakeStone StakeStone +29.44%
#8 BLOCKv BLOCKv +25.50%
#9 KONET KONET +24.76%
#10 OpenVPP OpenVPP +21.34%
Coin of the day
ONFA ONFA
Pengaturan
Bahasa
BAHASA INDONESIA
Mata uang
USD
Tema
Ensysce Biosciences, Inc. Ensysce Biosciences, Inc.

Ensysce Biosciences, Inc.

ENSC
Peringkat dalam Saham #19706
Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in... Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.
Harga Saham
$0.5275
Kapitalisasi Pasar
$1.25M
Perubahan (1 hari)
-3.56%
Perubahan (1 tahun)
-83.77%
Negara
US
Perdagangan Ensysce Biosciences, Inc. (ENSC)

Kategori

Healthcare
Jumlah saham beredar untuk Ensysce Biosciences, Inc. (ENSC)
Jumlah saham beredar per September 2025: 2.89M
Menurut laporan keuangan terbaru dan harga saham Ensysce Biosciences, Inc., jumlah saham beredar saat ini adalah 2.89M. Pada akhir December 2023, perusahaan memiliki 2.26M saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Ensysce Biosciences, Inc. (ENSC) dari 2017 hingga 2026
Saham beredar pada akhir setiap tahun
Tahun Saham Beredar Mengubah
2026 (TTM) 2.89M 65.20%
2024 1.75M -22.84%
2023 2.26M 1,158.25%
2022 179.93K 114.16%
2021 84.02K -98.12%
2020 4.46M -26.81%
2019 6.09M 1.42%
2018 6.01M 0.37%
2017 5.98M 0.00%
Saham beredar untuk perusahaan serupa atau pesaing
Perusahaan Saham Beredar Perbedaan Negara
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 154,015.04%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 8,697.46%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M 3,465.42%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 6,483.27%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 16,655.56%
AU